SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3nzu'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIA_A_SAMA293_0 (GLYCINE N-METHYLTRANSFERASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ILE A 828 GLY A 790 VAL A 785 TRP A 201 HIS A 295	None	0.96A	1kiaA-3nzuA: undetectable	1kiaA-3nzuA: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIA_B_SAMB1293_0 (GLYCINE N-METHYLTRANSFERASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ILE A 828 GLY A 790 VAL A 785 TRP A 201 HIS A 295	None	0.96A	1kiaB-3nzuA: undetectable	1kiaB-3nzuA: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIA_C_SAMC2293_0 (GLYCINE N-METHYLTRANSFERASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ILE A 828 GLY A 790 VAL A 785 TRP A 201 HIS A 295	None	0.95A	1kiaC-3nzuA: undetectable	1kiaC-3nzuA: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MZ9_A_VDYA1002_4 (CARTILAGE OLIGOMERIC MATRIX PROTEIN)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 5	VAL A 986 CYH A 936 ALA A 933 CYH A 932	None	1.11A	1mz9D-3nzuA: undetectable	1mz9D-3nzuA: 4.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NBH_A_SAMA293_0 (GLYCINE N-METHYLTRANSFERASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ILE A 828 GLY A 790 VAL A 785 TRP A 201 HIS A 295	None	0.96A	1nbhA-3nzuA: undetectable	1nbhA-3nzuA: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NBH_B_SAMB1293_0 (GLYCINE N-METHYLTRANSFERASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ILE A 828 GLY A 790 VAL A 785 TRP A 201 HIS A 295	None	0.97A	1nbhB-3nzuA: undetectable	1nbhB-3nzuA: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NBH_C_SAMC2293_0 (GLYCINE N-METHYLTRANSFERASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ILE A 828 GLY A 790 VAL A 785 TRP A 201 HIS A 295	None	0.97A	1nbhC-3nzuA: 2.3	1nbhC-3nzuA: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NBH_D_SAMD3293_0 (GLYCINE N-METHYLTRANSFERASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ILE A 828 GLY A 790 VAL A 785 TRP A 201 HIS A 295	None	0.96A	1nbhD-3nzuA: undetectable	1nbhD-3nzuA: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NBI_A_SAMA293_0 (GLYCINE N-METHYLTRANSFERASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ILE A 828 GLY A 790 VAL A 785 TRP A 201 HIS A 295	None	0.96A	1nbiA-3nzuA: undetectable	1nbiA-3nzuA: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NBI_B_SAMB1293_0 (GLYCINE N-METHYLTRANSFERASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ILE A 828 GLY A 790 VAL A 785 TRP A 201 HIS A 295	None	0.98A	1nbiB-3nzuA: undetectable	1nbiB-3nzuA: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NW3_A_SAMA500_1 (HISTONE METHYLTRANSFERASE DOT1L)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 4	THR A 155 GLN A 151 GLU A 174 ASP A 170	None	1.49A	1nw3A-3nzuA: 0.0	1nw3A-3nzuA: 18.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q23_D_FUAD705_1 (CHLORAMPHENICOL ACETYLTRANSFERASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	SER A 620 LEU A 611 VAL A 640 PHE A 593 ALA A 644	None	1.33A	1q23D-3nzuA: undetectable 1q23E-3nzuA: undetectable	1q23D-3nzuA: 12.56 1q23E-3nzuA: 12.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T87_B_CAMB2422_0 (CYTOCHROME P450-CAM)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	THR A 399 LEU A 414 VAL A 363 ILE A 516	None	0.98A	1t87B-3nzuA: undetectable	1t87B-3nzuA: 17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WRL_A_TFPA204_1 (TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	PHE A 815 LEU A 771 PHE A 783 VAL A 736	None	0.87A	1wrlA-3nzuA: undetectable 1wrlB-3nzuA: undetectable	1wrlA-3nzuA: 6.00 1wrlB-3nzuA: 6.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WRL_F_TFPF211_1 (TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	LEU A 813 PHE A 815 LEU A 771 PHE A 783	None	0.85A	1wrlE-3nzuA: undetectable 1wrlF-3nzuA: undetectable	1wrlE-3nzuA: 6.00 1wrlF-3nzuA: 6.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OAX_D_SNLD4001_1 (MINERALOCORTICOID RECEPTOR)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	LEU A 848 LEU A 661 GLN A 665 MET A1039 LEU A 969	None	1.25A	2oaxD-3nzuA: undetectable	2oaxD-3nzuA: 13.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ADX_A_IMNA2_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	ILE A 952 LEU A 960 PHE A 961 LEU A 845	None	0.81A	3adxA-3nzuA: undetectable	3adxA-3nzuA: 15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FXR_A_ASCA3001_0 (LYSR TYPE REGULATOR OF TSAMBCD)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 8	ALA A 216 ILE A 215 ASN A 217 PRO A 237	None	0.86A	3fxrA-3nzuA: 0.6	3fxrA-3nzuA: 15.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IK3_B_0LIB2_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	LEU A 461 TYR A 462 VAL A 363 ARG A 476	None	1.18A	3ik3B-3nzuA: 2.7	3ik3B-3nzuA: 15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LMY_A_CP6A562_1 (BETA-HEXOSAMINIDASE SUBUNIT BETA)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ASP A 171 HIS A 471 ASP A 470 TYR A 480 LEU A 482	None	1.34A	3lmyA-3nzuA: undetectable	3lmyA-3nzuA: 19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TJ7_A_ACTA604_0 (GBAA_1210 PROTEIN)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 6	VAL A 223 HIS A 225 SER A 230 THR A 232	None	0.58A	3tj7A-3nzuA: undetectable 3tj7B-3nzuA: undetectable	3tj7A-3nzuA: 11.72 3tj7B-3nzuA: 11.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TJ7_C_ACTC606_0 (GBAA_1210 PROTEIN)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 6	VAL A 223 HIS A 225 SER A 230 THR A 232	None	0.56A	3tj7C-3nzuA: undetectable 3tj7D-3nzuA: undetectable	3tj7C-3nzuA: 11.72 3tj7D-3nzuA: 11.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TJ7_D_ACTD605_0 (GBAA_1210 PROTEIN)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 6	VAL A 223 HIS A 225 SER A 230 THR A 232	None	0.56A	3tj7C-3nzuA: undetectable 3tj7D-3nzuA: undetectable	3tj7C-3nzuA: 11.72 3tj7D-3nzuA: 11.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AQ7_A_LEUA902_0 (LEUCINE--TRNA LIGASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	SER A 230 GLU A 302 HIS A 304 HIS A 225	None	1.30A	4aq7A-3nzuA: 2.5	4aq7A-3nzuA: 22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FOG_A_C2FA302_0 (THYMIDYLATE SYNTHASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 11	HIS A 962 ILE A 963 ASP A 836 GLY A 966 PHE A 965	None NZU A 1 (-3.7A) None None None	1.36A	4fogA-3nzuA: undetectable	4fogA-3nzuA: 14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FOX_F_D16F301_1 (THYMIDYLATE SYNTHASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 11	HIS A 962 ILE A 963 ASP A 836 GLY A 966 PHE A 965	None NZU A 1 (-3.7A) None None None	1.47A	4foxF-3nzuA: undetectable	4foxF-3nzuA: 14.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	ILE A 879 VAL A 882 THR A 887 MET A 953 ILE A 963	NZU A 1 (-4.2A) NZU A 1 (-3.9A) NZU A 1 (-3.8A) NZU A 1 (-3.5A) NZU A 1 (-3.7A)	0.98A	4xe0A-3nzuA: 33.3	4xe0A-3nzuA: 35.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	6 / 12	MET A 804 PRO A 810 TYR A 867 VAL A 882 MET A 953 ILE A 963	NZU A 1 (-4.7A) None NZU A 1 (-3.5A) NZU A 1 (-3.9A) NZU A 1 (-3.5A) NZU A 1 (-3.7A)	1.29A	4xe0A-3nzuA: 33.3	4xe0A-3nzuA: 35.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	PRO A 810 ILE A 831 THR A 887 ILE A 963 ASP A 964	None NZU A 1 (-4.9A) NZU A 1 (-3.8A) NZU A 1 (-3.7A) NZU A 1 (-4.1A)	0.87A	4xe0A-3nzuA: 33.3	4xe0A-3nzuA: 35.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	8 / 12	PRO A 810 TRP A 812 ILE A 831 TYR A 867 VAL A 882 THR A 887 MET A 953 ILE A 963	None None NZU A 1 (-4.9A) NZU A 1 (-3.5A) NZU A 1 (-3.9A) NZU A 1 (-3.8A) NZU A 1 (-3.5A) NZU A 1 (-3.7A)	0.46A	4xe0A-3nzuA: 33.3	4xe0A-3nzuA: 35.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	LEU A 987 ILE A 888 ILE A 952 LEU A 911 PHE A 928	None	1.21A	4y0pA-3nzuA: undetectable	4y0pA-3nzuA: 9.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZE2_A_1YNA602_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 5	ALA A1064 TYR A1067 HIS A 962 PHE A 940	None	1.23A	4ze2A-3nzuA: undetectable	4ze2A-3nzuA: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BS8_G_MFXG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	ASP A 653 ARG A 687 GLY A 685 GLU A 187	None	0.86A	5bs8A-3nzuA: undetectable 5bs8C-3nzuA: 1.5 5bs8D-3nzuA: undetectable	5bs8A-3nzuA: 19.26 5bs8C-3nzuA: 19.26 5bs8D-3nzuA: 13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BS8_H_MFXH101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER GGTCATGAATGACTATGCAC GTAA)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	ASP A 653 ARG A 687 GLY A 685 GLU A 187	None	0.88A	5bs8A-3nzuA: 1.5 5bs8B-3nzuA: undetectable 5bs8C-3nzuA: undetectable	5bs8A-3nzuA: 19.26 5bs8B-3nzuA: 13.96 5bs8C-3nzuA: 19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTA_G_MFXG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	ASP A 653 ARG A 687 GLY A 685 GLU A 187	None	0.81A	5btaA-3nzuA: 1.6 5btaC-3nzuA: 1.6 5btaD-3nzuA: undetectable	5btaA-3nzuA: 19.26 5btaC-3nzuA: 19.26 5btaD-3nzuA: 13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTD_E_GFNE101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER GGTCATGAATGACTATGCAC GTAA)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	ASP A 653 ARG A 687 GLY A 685 GLU A 187	None	0.86A	5btdA-3nzuA: 1.5 5btdB-3nzuA: undetectable 5btdC-3nzuA: 1.6	5btdA-3nzuA: 19.26 5btdB-3nzuA: 13.96 5btdC-3nzuA: 19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTD_G_GFNG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	ASP A 653 ARG A 687 GLY A 685 GLU A 187	None	0.87A	5btdA-3nzuA: 1.5 5btdC-3nzuA: 1.6 5btdD-3nzuA: undetectable	5btdA-3nzuA: 19.26 5btdC-3nzuA: 19.26 5btdD-3nzuA: 13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTF_F_GFNF101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	ASP A 653 ARG A 687 GLY A 685 GLU A 187	None	0.90A	5btfA-3nzuA: 1.5 5btfB-3nzuA: undetectable 5btfC-3nzuA: 1.6	5btfA-3nzuA: 19.26 5btfB-3nzuA: 13.96 5btfC-3nzuA: 19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTG_F_LFXF101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	ASP A 653 ARG A 687 GLY A 685 GLU A 187	None	0.93A	5btgA-3nzuA: undetectable 5btgC-3nzuA: 1.5 5btgD-3nzuA: undetectable	5btgA-3nzuA: 19.26 5btgC-3nzuA: 19.26 5btgD-3nzuA: 13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5K9D_A_ACTA405_0 (DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	3 / 3	GLN A 151 THR A 155 ASP A 161	None	0.83A	5k9dA-3nzuA: undetectable	5k9dA-3nzuA: 17.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NFP_A_8W5A804_2 (GLUCOCORTICOID RECEPTOR)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 4	LEU A1030 MET A 851 ILE A1048 LEU A 942	None	1.33A	5nfpA-3nzuA: undetectable	5nfpA-3nzuA: 13.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC3_A_486A801_2 (GLUCOCORTICOID RECEPTOR)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 5	LEU A1027 LEU A1026 MET A1034 TYR A1050	None	1.42A	5uc3A-3nzuA: undetectable	5uc3A-3nzuA: 6.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCE_A_RITA602_2 (CYTOCHROME P450 3A4)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 6	ARG A 927 PHE A 921 ILE A 954 THR A 955	None	0.92A	5vceA-3nzuA: undetectable	5vceA-3nzuA: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X23_A_LSNA504_1 (CYTOCHROME P450 2C9)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 8	ILE A 830 PHE A 783 THR A 872 PRO A 786	None	1.09A	5x23A-3nzuA: undetectable	5x23A-3nzuA: 20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DH0_A_017A101_2 (PROTEASE)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	3 / 3	LEU A 843 ASP A 964 ILE A 879	None NZU A 1 (-4.1A) NZU A 1 (-4.2A)	0.60A	6dh0B-3nzuA: undetectable	6dh0B-3nzuA: 6.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DLZ_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 10	LEU A 838 ASP A 837 ILE A 739 PRO A 786 SER A 701	None	1.37A	6dlzB-3nzuA: undetectable 6dlzC-3nzuA: undetectable	6dlzB-3nzuA: 7.54 6dlzC-3nzuA: 7.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DLZ_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 11	ILE A 739 PRO A 786 SER A 701 LEU A 838 ASP A 837	None	1.36A	6dlzA-3nzuA: undetectable 6dlzD-3nzuA: undetectable	6dlzA-3nzuA: 7.54 6dlzD-3nzuA: 7.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM1_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 10	LEU A 838 ASP A 837 ILE A 739 PRO A 786 SER A 701	None	1.38A	6dm1B-3nzuA: undetectable 6dm1C-3nzuA: undetectable	6dm1B-3nzuA: 7.54 6dm1C-3nzuA: 7.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM1_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 11	ILE A 739 PRO A 786 SER A 701 LEU A 838 ASP A 837	None	1.36A	6dm1A-3nzuA: undetectable 6dm1D-3nzuA: undetectable	6dm1A-3nzuA: 7.54 6dm1D-3nzuA: 7.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM2_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 10	LEU A 838 ASP A 837 ILE A 739 PRO A 786 SER A 701	None	1.37A	6dm2B-3nzuA: undetectable 6dm2C-3nzuA: undetectable	6dm2B-3nzuA: 7.54 6dm2C-3nzuA: 7.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM2_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 10	ILE A 739 PRO A 786 SER A 701 LEU A 838 ASP A 837	None	1.37A	6dm2A-3nzuA: undetectable 6dm2D-3nzuA: undetectable	6dm2A-3nzuA: 7.54 6dm2D-3nzuA: 7.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_S_PCFS603_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 8 CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	4 / 7	GLY A 996 PHE A1006 HIS A1005 VAL A 929	None	0.98A	6hu9S-3nzuA: undetectable 6hu9q-3nzuA: 1.8	6hu9S-3nzuA: 7.11 6hu9q-3nzuA: 9.59

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1KIA_A_SAMA293_0","GLYCINE N-METHYLTRANSFERASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 828;GLY A 790;VAL A 785;TRP A 201;HIS A 295","None","0.96A","1kiaA-3nzuA:undetectable","1kiaA-3nzuA:15.14"],["1KIA_B_SAMB1293_0","GLYCINE N-METHYLTRANSFERASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 828;GLY A 790;VAL A 785;TRP A 201;HIS A 295","None","0.96A","1kiaB-3nzuA:undetectable","1kiaB-3nzuA:15.14"],["1KIA_C_SAMC2293_0","GLYCINE N-METHYLTRANSFERASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 828;GLY A 790;VAL A 785;TRP A 201;HIS A 295","None","0.95A","1kiaC-3nzuA:undetectable","1kiaC-3nzuA:15.14"],["1MZ9_A_VDYA1002_4","CARTILAGE OLIGOMERIC MATRIX PROTEIN;CARTILAGE OLIGOMERIC MATRIX PROTEIN","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"VAL A 986;CYH A 936;ALA A 933;CYH A 932","None","1.11A","1mz9D-3nzuA:undetectable","1mz9D-3nzuA:4.49"],["1NBH_A_SAMA293_0","GLYCINE N-METHYLTRANSFERASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 828;GLY A 790;VAL A 785;TRP A 201;HIS A 295","None","0.96A","1nbhA-3nzuA:undetectable","1nbhA-3nzuA:15.14"],["1NBH_B_SAMB1293_0","GLYCINE N-METHYLTRANSFERASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 828;GLY A 790;VAL A 785;TRP A 201;HIS A 295","None","0.97A","1nbhB-3nzuA:undetectable","1nbhB-3nzuA:15.14"],["1NBH_C_SAMC2293_0","GLYCINE N-METHYLTRANSFERASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 828;GLY A 790;VAL A 785;TRP A 201;HIS A 295","None","0.97A","1nbhC-3nzuA:2.3","1nbhC-3nzuA:15.14"],["1NBH_D_SAMD3293_0","GLYCINE N-METHYLTRANSFERASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 828;GLY A 790;VAL A 785;TRP A 201;HIS A 295","None","0.96A","1nbhD-3nzuA:undetectable","1nbhD-3nzuA:15.14"],["1NBI_A_SAMA293_0","GLYCINE N-METHYLTRANSFERASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 828;GLY A 790;VAL A 785;TRP A 201;HIS A 295","None","0.96A","1nbiA-3nzuA:undetectable","1nbiA-3nzuA:15.14"],["1NBI_B_SAMB1293_0","GLYCINE N-METHYLTRANSFERASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 828;GLY A 790;VAL A 785;TRP A 201;HIS A 295","None","0.98A","1nbiB-3nzuA:undetectable","1nbiB-3nzuA:15.14"],["1NW3_A_SAMA500_1","HISTONE METHYLTRANSFERASE DOT1L","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"THR A 155;GLN A 151;GLU A 174;ASP A 170","None","1.49A","1nw3A-3nzuA:0.0","1nw3A-3nzuA:18.39"],["1Q23_D_FUAD705_1","CHLORAMPHENICOL ACETYLTRANSFERASE;CHLORAMPHENICOL ACETYLTRANSFERASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"SER A 620;LEU A 611;VAL A 640;PHE A 593;ALA A 644","None","1.33A","1q23D-3nzuA:undetectable;1q23E-3nzuA:undetectable","1q23D-3nzuA:12.56;1q23E-3nzuA:12.56"],["1T87_B_CAMB2422_0","CYTOCHROME P450-CAM","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"THR A 399;LEU A 414;VAL A 363;ILE A 516","None","0.98A","1t87B-3nzuA:undetectable","1t87B-3nzuA:17.36"],["1WRL_A_TFPA204_1","TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES;TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"PHE A 815;LEU A 771;PHE A 783;VAL A 736","None","0.87A","1wrlA-3nzuA:undetectable;1wrlB-3nzuA:undetectable","1wrlA-3nzuA:6.00;1wrlB-3nzuA:6.00"],["1WRL_F_TFPF211_1","TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES;TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"LEU A 813;PHE A 815;LEU A 771;PHE A 783","None","0.85A","1wrlE-3nzuA:undetectable;1wrlF-3nzuA:undetectable","1wrlE-3nzuA:6.00;1wrlF-3nzuA:6.00"],["2OAX_D_SNLD4001_1","MINERALOCORTICOID RECEPTOR","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"LEU A 848;LEU A 661;GLN A 665;MET A1039;LEU A 969","None","1.25A","2oaxD-3nzuA:undetectable","2oaxD-3nzuA:13.87"],["3ADX_A_IMNA2_2","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ILE A 952;LEU A 960;PHE A 961;LEU A 845","None","0.81A","3adxA-3nzuA:undetectable","3adxA-3nzuA:15.38"],["3FXR_A_ASCA3001_0","LYSR TYPE REGULATOR OF TSAMBCD","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ALA A 216;ILE A 215;ASN A 217;PRO A 237","None","0.86A","3fxrA-3nzuA:0.6","3fxrA-3nzuA:15.51"],["3IK3_B_0LIB2_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"LEU A 461;TYR A 462;VAL A 363;ARG A 476","None","1.18A","3ik3B-3nzuA:2.7","3ik3B-3nzuA:15.12"],["3LMY_A_CP6A562_1","BETA-HEXOSAMINIDASE SUBUNIT BETA","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ASP A 171;HIS A 471;ASP A 470;TYR A 480;LEU A 482","None","1.34A","3lmyA-3nzuA:undetectable","3lmyA-3nzuA:19.63"],["3TJ7_A_ACTA604_0","GBAA_1210 PROTEIN","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"VAL A 223;HIS A 225;SER A 230;THR A 232","None","0.58A","3tj7A-3nzuA:undetectable;3tj7B-3nzuA:undetectable","3tj7A-3nzuA:11.72;3tj7B-3nzuA:11.72"],["3TJ7_C_ACTC606_0","GBAA_1210 PROTEIN","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"VAL A 223;HIS A 225;SER A 230;THR A 232","None","0.56A","3tj7C-3nzuA:undetectable;3tj7D-3nzuA:undetectable","3tj7C-3nzuA:11.72;3tj7D-3nzuA:11.72"],["3TJ7_D_ACTD605_0","GBAA_1210 PROTEIN","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"VAL A 223;HIS A 225;SER A 230;THR A 232","None","0.56A","3tj7C-3nzuA:undetectable;3tj7D-3nzuA:undetectable","3tj7C-3nzuA:11.72;3tj7D-3nzuA:11.72"],["4AQ7_A_LEUA902_0","LEUCINE--TRNA LIGASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"SER A 230;GLU A 302;HIS A 304;HIS A 225","None","1.30A","4aq7A-3nzuA:2.5","4aq7A-3nzuA:22.63"],["4FOG_A_C2FA302_0","THYMIDYLATE SYNTHASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"HIS A 962;ILE A 963;ASP A 836;GLY A 966;PHE A 965","None;NZU A   1 (-3.7A);None;None;None","1.36A","4fogA-3nzuA:undetectable","4fogA-3nzuA:14.36"],["4FOX_F_D16F301_1","THYMIDYLATE SYNTHASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"HIS A 962;ILE A 963;ASP A 836;GLY A 966;PHE A 965","None;NZU A   1 (-3.7A);None;None;None","1.47A","4foxF-3nzuA:undetectable","4foxF-3nzuA:14.36"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 879;VAL A 882;THR A 887;MET A 953;ILE A 963","NZU A   1 (-4.2A);NZU A   1 (-3.9A);NZU A   1 (-3.8A);NZU A   1 (-3.5A);NZU A   1 (-3.7A)","0.98A","4xe0A-3nzuA:33.3","4xe0A-3nzuA:35.86"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",6,"MET A 804;PRO A 810;TYR A 867;VAL A 882;MET A 953;ILE A 963","NZU A   1 (-4.7A);None;NZU A   1 (-3.5A);NZU A   1 (-3.9A);NZU A   1 (-3.5A);NZU A   1 (-3.7A)","1.29A","4xe0A-3nzuA:33.3","4xe0A-3nzuA:35.86"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"PRO A 810;ILE A 831;THR A 887;ILE A 963;ASP A 964","None;NZU A   1 (-4.9A);NZU A   1 (-3.8A);NZU A   1 (-3.7A);NZU A   1 (-4.1A)","0.87A","4xe0A-3nzuA:33.3","4xe0A-3nzuA:35.86"],["4XE0_A_40LA1101_0","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",8,"PRO A 810;TRP A 812;ILE A 831;TYR A 867;VAL A 882;THR A 887;MET A 953;ILE A 963","None;None;NZU A   1 (-4.9A);NZU A   1 (-3.5A);NZU A   1 (-3.9A);NZU A   1 (-3.8A);NZU A   1 (-3.5A);NZU A   1 (-3.7A)","0.46A","4xe0A-3nzuA:33.3","4xe0A-3nzuA:35.86"],["4Y0P_A_TE4A201_1","BETA-LACTOGLOBULIN","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"LEU A 987;ILE A 888;ILE A 952;LEU A 911;PHE A 928","None","1.21A","4y0pA-3nzuA:undetectable","4y0pA-3nzuA:9.95"],["4ZE2_A_1YNA602_2","LANOSTEROL 14-ALPHA DEMETHYLASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ALA A1064;TYR A1067;HIS A 962;PHE A 940","None","1.23A","4ze2A-3nzuA:undetectable","4ze2A-3nzuA:20.98"],["5BS8_G_MFXG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ASP A 653;ARG A 687;GLY A 685;GLU A 187","None","0.86A","5bs8A-3nzuA:undetectable;5bs8C-3nzuA:1.5;5bs8D-3nzuA:undetectable","5bs8A-3nzuA:19.26;5bs8C-3nzuA:19.26;5bs8D-3nzuA:13.96"],["5BS8_H_MFXH101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A;DNA SUBSTRATE 24-MER GGTCATGAATGACTATGCACGTAA","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ASP A 653;ARG A 687;GLY A 685;GLU A 187","None","0.88A","5bs8A-3nzuA:1.5;5bs8B-3nzuA:undetectable;5bs8C-3nzuA:undetectable","5bs8A-3nzuA:19.26;5bs8B-3nzuA:13.96;5bs8C-3nzuA:19.26"],["5BTA_G_MFXG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ASP A 653;ARG A 687;GLY A 685;GLU A 187","None","0.81A","5btaA-3nzuA:1.6;5btaC-3nzuA:1.6;5btaD-3nzuA:undetectable","5btaA-3nzuA:19.26;5btaC-3nzuA:19.26;5btaD-3nzuA:13.96"],["5BTD_E_GFNE101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A;DNA SUBSTRATE 24-MER GGTCATGAATGACTATGCACGTAA","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ASP A 653;ARG A 687;GLY A 685;GLU A 187","None","0.86A","5btdA-3nzuA:1.5;5btdB-3nzuA:undetectable;5btdC-3nzuA:1.6","5btdA-3nzuA:19.26;5btdB-3nzuA:13.96;5btdC-3nzuA:19.26"],["5BTD_G_GFNG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ASP A 653;ARG A 687;GLY A 685;GLU A 187","None","0.87A","5btdA-3nzuA:1.5;5btdC-3nzuA:1.6;5btdD-3nzuA:undetectable","5btdA-3nzuA:19.26;5btdC-3nzuA:19.26;5btdD-3nzuA:13.96"],["5BTF_F_GFNF101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ASP A 653;ARG A 687;GLY A 685;GLU A 187","None","0.90A","5btfA-3nzuA:1.5;5btfB-3nzuA:undetectable;5btfC-3nzuA:1.6","5btfA-3nzuA:19.26;5btfB-3nzuA:13.96;5btfC-3nzuA:19.26"],["5BTG_F_LFXF101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ASP A 653;ARG A 687;GLY A 685;GLU A 187","None","0.93A","5btgA-3nzuA:undetectable;5btgC-3nzuA:1.5;5btgD-3nzuA:undetectable","5btgA-3nzuA:19.26;5btgC-3nzuA:19.26;5btgD-3nzuA:13.96"],["5K9D_A_ACTA405_0","DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",3,"GLN A 151;THR A 155;ASP A 161","None","0.83A","5k9dA-3nzuA:undetectable","5k9dA-3nzuA:17.75"],["5NFP_A_8W5A804_2","GLUCOCORTICOID RECEPTOR","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"LEU A1030;MET A 851;ILE A1048;LEU A 942","None","1.33A","5nfpA-3nzuA:undetectable","5nfpA-3nzuA:13.82"],["5UC3_A_486A801_2","GLUCOCORTICOID RECEPTOR","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"LEU A1027;LEU A1026;MET A1034;TYR A1050","None","1.42A","5uc3A-3nzuA:undetectable","5uc3A-3nzuA:6.32"],["5VCE_A_RITA602_2","CYTOCHROME P450 3A4","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ARG A 927;PHE A 921;ILE A 954;THR A 955","None","0.92A","5vceA-3nzuA:undetectable","5vceA-3nzuA:21.18"],["5X23_A_LSNA504_1","CYTOCHROME P450 2C9","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"ILE A 830;PHE A 783;THR A 872;PRO A 786","None","1.09A","5x23A-3nzuA:undetectable","5x23A-3nzuA:20.17"],["6DH0_A_017A101_2","PROTEASE","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",3,"LEU A 843;ASP A 964;ILE A 879","None;NZU A   1 (-4.1A);NZU A   1 (-4.2A)","0.60A","6dh0B-3nzuA:undetectable","6dh0B-3nzuA:6.53"],["6DLZ_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"LEU A 838;ASP A 837;ILE A 739;PRO A 786;SER A 701","None","1.37A","6dlzB-3nzuA:undetectable;6dlzC-3nzuA:undetectable","6dlzB-3nzuA:7.54;6dlzC-3nzuA:7.54"],["6DLZ_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 739;PRO A 786;SER A 701;LEU A 838;ASP A 837","None","1.36A","6dlzA-3nzuA:undetectable;6dlzD-3nzuA:undetectable","6dlzA-3nzuA:7.54;6dlzD-3nzuA:7.54"],["6DM1_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"LEU A 838;ASP A 837;ILE A 739;PRO A 786;SER A 701","None","1.38A","6dm1B-3nzuA:undetectable;6dm1C-3nzuA:undetectable","6dm1B-3nzuA:7.54;6dm1C-3nzuA:7.54"],["6DM1_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 739;PRO A 786;SER A 701;LEU A 838;ASP A 837","None","1.36A","6dm1A-3nzuA:undetectable;6dm1D-3nzuA:undetectable","6dm1A-3nzuA:7.54;6dm1D-3nzuA:7.54"],["6DM2_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"LEU A 838;ASP A 837;ILE A 739;PRO A 786;SER A 701","None","1.37A","6dm2B-3nzuA:undetectable;6dm2C-3nzuA:undetectable","6dm2B-3nzuA:7.54;6dm2C-3nzuA:7.54"],["6DM2_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",5,"ILE A 739;PRO A 786;SER A 701;LEU A 838;ASP A 837","None","1.37A","6dm2A-3nzuA:undetectable;6dm2D-3nzuA:undetectable","6dm2A-3nzuA:7.54;6dm2D-3nzuA:7.54"],["6HU9_S_PCFS603_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 8;CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL","3nzu","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","Homo sapiens",4,"GLY A 996;PHE A1006;HIS A1005;VAL A 929","None","0.98A","6hu9S-3nzuA:undetectable;6hu9q-3nzuA:1.8","6hu9S-3nzuA:7.11;6hu9q-3nzuA:9.59"]]